Harnessing Genomic Data: An Interview with Ben Salisbury, V.P. of GenomOncology

GenomOncology, a Cleveland-based healthcare technology company founded in 2012, works to provide actionable insights for clinicians and researchers via genomic analysis tools and services. Institution-tailored implementations of their GO Precision Medicine Portfolio enable the streamlined development, validation, and eventual clinical adoption of cancer and hereditary disease tests. These targeted tests unlock detailed, individualized patient information that guides the treatment decisions made by clinicians and, ultimately, improves patient outcomes. (Read More)